[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#pubInfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/MONDO_0004985",
    "@type" : [ "https://w3id.org/biolink/vocab/Disease" ]
  }, {
    "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/MONDO_0004985"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/DRUGBANK:DB00734"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "When we asked about the long-term treatment of BD, after having excluded from the analyses the 3 SGAs with a European indication for maintenance BD treatment (aripiprazole, olanzapine, and quetiapine), asenapine was considered either “highly appropriate” or “appropriate” by 44.6% of the respondents, while other off-label SGAs (clozapine, paliperidone, risperidone, ziprasidone) were mostly considered inappro- priate for maintenance bipolar treatment"
    } ],
    "https://w3id.org/biolink/vocab/has_population_context" : [ {
      "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#context"
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/publications" : [ {
      "@id" : "https://pubmed.ncbi.nlm.nih.gov/31291215"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://w3id.org/um/neurodkg/OffLabelIndication"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#context",
    "@type" : [ "https://w3id.org/biolink/vocab/Cohort" ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Adults"
    } ]
  }, {
    "@id" : "https://identifiers.org/DRUGBANK:DB00734",
    "@type" : [ "https://w3id.org/biolink/vocab/Drug" ]
  } ],
  "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#assertion",
    "http://www.w3.org/ns/prov#generatedAtTime" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-08-17T13:35:51.063600"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU",
    "http://www.w3.org/ns/prov#generatedAtTime" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-08-17T13:35:51.063600"
    } ],
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-7641-6446"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "kYj+cgZGV/ADRMOPicQhPuGaPOBRQzx/40hrrPzYCmGFXxjw6XhltP1OA2m6zIgknurH4c3TDksrBEuSZ1QPaRmvGDAQCARvySmpxlzwNhCPIwc/RwbK9oft8lXooD+ZQcqBUJ2lE91ulLIwL1YjirBdKSmX6Oj0WDitzFzgAE8="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAprdeg28P4SccrQhTw8saG9-CHRbSCfj3o4F-PRaN8uU#pubInfo"
} ]